Upgraded Upp Technology irms|EM software streamlines H1N1 vaccine distribution

NewsGuard 100/100 Score

Based on feedback from their national client base of Public Health Agencies and First Responders, Upp Technology has added significant enhancements to its already award winning irms|EM (Emergency Management) software. The new irms|EM product enhancements streamline the order fulfillment and distribution process of H1N1 vaccines and Personal Protective Equipment (PPE) to partner agencies, private facilities, as well as, the general public.

"Our collaborative, hands-on approach to business allows us to understand our client’s mission and provide them with sustainable business value,” said Carl Brewer, President of Upp Technology. “With 10 states slotted to complete the upgrade in September, irms|EM will be well positioned to handle the upcoming H1N1 vaccine distribution."

Significant among many new features is a streamlined order entry process and Decision Support System (DSS) to facilitate large scale pushes of vaccines, antiviral, and PPE’s to many destinations. Other enhancements include a robust set of filters for grouping, releasing, and prioritization of orders by state, region, county, city, or provider. New dashboards provide real-time graphical visibility of the order fulfillment activity giving management cutting edge analytical tools to gauge ongoing performance. Import tools and reports have also been bolstered, and changes have been made to the mobile platform to strengthen performance and add more robust patient management and dispensing capabilities.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New vaccine promises broad protection against SARS-CoV-2 and other sarbecoviruses